Oe PL - Search Results

1

In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.

de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Verhoef J, Donker AJ. de Fijter CW, et al. Among authors: oe pl. Clin Nephrol. 1993 Feb;39(2):75-80. Clin Nephrol. 1993. PMID: 8448921 Clinical Trial.

2

Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages.

de Fijter CW, Verbrugh HA, Heezius HC, van der Meulen J, Oe PL, Donker AJ, Verhoef J. de Fijter CW, et al. Among authors: oe pl. J Antimicrob Chemother. 1990 Oct;26(4):525-32. doi: 10.1093/jac/26.4.525. J Antimicrob Chemother. 1990. PMID: 2254222 Clinical Trial.

3

Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro.

van Bronswijk H, Verbrugh HA, Bos HJ, Heezius EC, Oe PL, van der Meulen J, Verhoef J. van Bronswijk H, et al. Among authors: oe pl. Perit Dial Int. 1989;9(3):197-202. Perit Dial Int. 1989. PMID: 2488365

4

Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?

de Fijter CW, Verbrugh HA, Heezius HC, van Bronswijk H, van der Meulen J, Oe PL, Donker AJ, Verhoef J. de Fijter CW, et al. Among authors: oe pl. Adv Perit Dial. 1989;5:124-7. Adv Perit Dial. 1989. PMID: 2577393 Clinical Trial.

5

The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.

Vlaanderen K, de Fijter CW, Bos HJ, van der Meulen J, Beelen RH, Oe PL, Verbrugh HA. Vlaanderen K, et al. Among authors: oe pl. Adv Perit Dial. 1989;5:151-3. Adv Perit Dial. 1989. PMID: 2577399

6

Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.

van Bronswijk H, Verbrugh HA, Heezius HC, van der Meulen J, Oe PL, Verhoef J. van Bronswijk H, et al. Among authors: oe pl. Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):368-73. doi: 10.1007/BF01962339. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3137037

7

Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor.

Verbrugh HA, van Bronswijk H, van der Meulen J, Oe PL, Verhoef J. Verbrugh HA, et al. Among authors: oe pl. Contrib Nephrol. 1987;57:85-91. Contrib Nephrol. 1987. PMID: 3677705 No abstract available.

8

Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis.

Oe PL, Lips P, van der Meulen J, de Vries PM, van Bronswijk H, Donker AJ. Oe PL, et al. Clin Nephrol. 1987 Oct;28(4):180-5. Clin Nephrol. 1987. PMID: 3690899

9

Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?

de Fijter CW, Verbrugh HA, Oe PL, Heezius EC, Verhoef J, Donker AJ. de Fijter CW, et al. Among authors: oe pl. Nephrol Dial Transplant. 1994;9(2):156-62. Nephrol Dial Transplant. 1994. PMID: 8190329 Clinical Trial.

10

Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.

Brulez HF, Dekker HA, Oe PL, Verbeelen D, ter Wee PM, Verbrugh HA. Brulez HF, et al. Among authors: oe pl. Nephron. 1996;74(1):26-32. doi: 10.1159/000189277. Nephron. 1996. PMID: 8883016 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters